MACC1 Antibody, FITC conjugated

說明書

中文名稱：

MACC1兔多克隆抗體, FITC偶聯(lián)
貨號：

CSB-PA761627LC01HU
規(guī)格：

￥880
其他：

產(chǎn)品詳情
產(chǎn)品評價
相關(guān)產(chǎn)品
靶點詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) MACC1 Polyclonal antibody
Uniprot No.：

Q6ZN28
基因名：

MACC1
別名：

7A5 antibody; MACC1 antibody; MACC1_HUMAN antibody; Metastasis associated in colon cancer 1 antibody; Metastasis-associated in colon cancer protein 1 antibody; OTTHUMP00000201891 antibody; Putative binding protein 7a5 antibody; SH3 domain-containing protein 7a5 antibody; SH3BP4L antibody
宿主：

Rabbit
反應(yīng)種屬：

Human
免疫原：

Recombinant Human Metastasis-associated in colon cancer protein 1 protein (371-514AA)
免疫原種屬：

Homo sapiens (Human)
標(biāo)記方式：

FITC
克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產(chǎn)品提供形式：

Liquid
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

功能：

Acts as a transcription activator for MET and as a key regulator of HGF-MET signaling. Promotes cell motility, proliferation and hepatocyte growth factor (HGF)-dependent scattering in vitro and tumor growth and metastasis in vivo.
基因功能參考文獻(xiàn)：
1. Expression levels of MACC1, CD44, Twist1, and KiSS-1 are related to duration of overall survival among patients with colonic adenocarcinoma. PMID: 30021598
2. Authors validated that metastasis associated in colon cancer-1 (MACC1) is a novel target of miR-598 in GBM. Restoring MACC1 expression reversed the inhibitory effects of miR-598 overexpression on GBM cells. PMID: 29444745
3. These results demonstrated that miR485 may perform its tumor suppressive function in cervical cancer by directly targeting MACC1 and inhibiting the Met/AKT signaling pathway. Therefore, the miR485/MACC1 axis may be a novel and effective therapeutic target in cervical cancer. PMID: 29916552
4. MACC1 is an independent prognostic marker in patients with small invasive lung adenocarcinoma after complete surgical resection. Differential outcomes are associated with MACC1 expression level. PMID: 29630522
5. MACC1 and c-Myc are highly expressed in serum and tumor tissues of EC patients. Both are correlated with TNM stage, primary infiltration, and lymph node or distal metastasis. PMID: 29984790
6. The results of this study found that MACC1 protein expression in tumor tissue is significantly prognostic for shorter disease-free survival. PMID: 29678846
7. miR-338-3p/MACC1/MAPK regulatory pathway play an important role in the progression of cervical cancer. PMID: 29243777
8. this study found that upregulation of MACC1 in ESCC was associated with lymph node metastasis of patients, and MACC1 regulated ESCC cell proliferation, apoptosis, migration and invasion mainly through AMPK-ULK1 induced autophagy PMID: 28791376
9. MACC1 overexpression is associated with poor survival rates, regional invasion and lymph-node metastasis [meta-analysis] PMID: 27542234
10. MACC1 expression stratifies colon cancer patients with unfavorable pMMR status. Stage II colon cancer patients with pMMR/MACC1-low tumors have a similar favorable prognosis to those with dMMR with potential implications for the role of adjuvant therapy PMID: 28460000
11. coexistence of high MACC1 and low NM23-H1 expression and tumor budding was associated with short overall survival PMID: 29700912
12. YB-1 promoted lung adenocarcinoma growth and progression in vitro and in vivo through directly binding to the MACC1 promoter and enhancing MACC1/c-Met pathway. PMID: 28624808
13. Serum metastasis-associated in colon cancer-1 (MACC1) levels were higher in breast cancer patients than patients with benign disease or healthy volunteers. PMID: 27793048
14. restoration of MACC1 expression could abrogate the anti-metastatic effects of miR-944 on colorectal cancer (CRC)cells with enhanced cell migration and invasion. MACC1/Met/AKT signaling may be implicated with the function of miR-944 in CRC cells. Altogether, miR-944 potentially act as a prognostic predictor and a drug-target for CRC patients. PMID: 28498456
15. Data suggest that the miR-497/MACC1 axis mediated the effect of XIST on GC cell growth. PMID: 27911852
16. these findings highlight the pivotal role of miR-218 in various aspects of MACC1 expression regulation and MACC1-mediated colorectal cancer progression PMID: 27462788
17. MACC1-induced tumor progression in colorectal cancer acts, at least in part, via the newly discovered MACC1/Nanog/Oct4 axis. PMID: 26758557
18. Data indicate that OR3A4 upregulation contributes to metastasis and tumorigenesis in gastric cancer by regulating the activation of PDLIM2, MACC1, NTN4, and GNB2L1. PMID: 26863570
19. H19 may regulate non-small cell lung cancer (NSCLC) metastasis through modulating cellular signaling pathway proteins related to cell proliferation and cell adhesion, including MACC1, EGFR, beta-catenin and ERK1/2. PMID: 27607135
20. Metastasis-associated in colon cancer 1 is expressed at early stages of colorectal oncogenesis within the affected colonic tissue in colorectal cancer patient cohort. PMID: 27439755
21. MACC1 is a key driver and prognostic biomarker for cancer progression and metastasis in a large variety of solid tumor types, particularly colorectal cancer (CRC). Data suggest that some small molecules with antineoplastic activity inhibit MACC1 transcription in CRC and prevent liver metastasis in CRC; lovastatin and rottlerin are the antineoplastic agents used here. PMID: 28570591
22. MACC1 regulates Fas mediated apoptosis through STAT1/3 - Mcl-1 signaling in solid cancers. PMID: 28649004
23. High expression of MACC1 is associated with non-small cell lung cancer. PMID: 27832750
24. MACC1 down-regulation suppresses endometrial carcinoma cell proliferation. PMID: 27991682
25. SPON2 is a transcriptional target of the metastasis gene MACC1. SPON2 induces cell motility in vitro and CRC metastasis in mice. In patients, SPON2 serves as prognostic indicator for CRC metastasis and survival, and might represent a promising target for therapeutic approaches. PMID: 26686083
26. High MACC1 expression is associated with Angiogenesis and recurrence in Gastric Cancer. PMID: 27280289
27. Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer. PMID: 27431311
28. Data show that metastasis-associated in colon cancer-1 (MACC1) and monocarboxylate transporter 1 (MCT1) are highly expressed in gastric cancer indicating poor prognosis. PMID: 28235486
29. A novel role of MACC1 in gastric cancer cell lipogenesis.MACC1 and FASN are positively correlated and responsible for the poor prognoses in gastric cancer patients. PMID: 28339092
30. MACC1 is more frequently expressed in a poor prognosis phenotype of gastric cancer and acts as a promising prognostic prediction parameter for gastric cancer PMID: 27143263
31. Results indicate that Nav 1.7 promotes GC progression through MACC1-mediated upregulation of NHE1. PMID: 27529686
32. MACC1 gene (metastasis-associated in colon cancer 1) is upregulated in cancer stem cells both resistant and sensitive to chemotherapy PMID: 27917797
33. MACC1 overexpression is associated with gastric cancer. PMID: 27793161
34. High MACC1 expression is associated with colorectal cancer. PMID: 27492459
35. Downregulation of MACC1 upregulates E-cadherin, N-cadherin and Vimentin in melanoma cell lines. PMID: 27488539
36. MACC1 is essential for acetylcholine-induced gastric cancer cell invasion/migration and epithelial-mesenchymal transition PMID: 26919111
37. Study demonstrated that suppression of MACC1 improves the chemosensitivity of cisplatin in epithelial ovarian cancer cells probably through regulation of the ERK1/2 signaling pathway and P-gp and its downstream apoptotic proteins. PMID: 26794135
38. MACC1 was a specific target gene of miR-338-3p, which regulates malignant biological behaviors of glioma cells partly through directly silencing MACC1 expression. PMID: 26936749
39. This study suggests that MACC1 is an independent prognostic factor in gastric adenocarcinoma and that the prognostic impact of MACC1 may be associated with MACC1 partners other than MET. PMID: 26719224
40. Metastasis-associated in colon cancer-1 may have an important role in tumour development in adenoid cystic carcinoma. Metastasis-associated in colon cancer-1 is a potential biomarker for adenoid cystic carcinoma. PMID: 25640194
41. downregulation of MACC1 expression could enhance cisplatin sensitivity and decrease drug resistance in SKOV- 3/DDP cells. PMID: 26681060
42. Our findings suggest that MACC1 protein, as a valuable marker of cervical cancer prognosis, plays an important role in the progression of human cervical cancer cells. PMID: 26332389
43. Our results suggest that rs975263 and rs4721888 polymorphisms in MACC1 are associated with the risk of breast cancer susceptibility and may be involved in the progression of breast cancer in Chinese women PMID: 26871844
44. Conclude that the ability of proliferation and invasion in T24 cells can be inhibited by RNAi-targeting MACC1. PMID: 26339359
45. the expression levels of MACC1 were significantly correlated with the biological processes underlying glioma cell proliferation, invasion and metastasis. PMID: 26043756
46. In renal cell carcinoma, positive MACC1 expression was found to significantly correlate with distant metastasis and TNM stage. patients with higher MACC1 expression had a significantly lower disease-free rate PMID: 26097569
47. conclusion, high MACC1 expression may serve as a prognostic biomarker to guide individualized management in clinical practice for digestive system neoplasms. PMID: 26090393
48. MACC1 promotes vasculogenic mimicry in gastric cancer by regulating the HGF/c-Met-TWIST1/2 signaling pathway. PMID: 25895023
49. MACC1 expression predicts survival outcome in colorectal cancer patients. PMID: 25884643
50. These results suggested that MACC1 leads to a poor prognosis in HCC, partly by promoting proliferation via enhancement in glucose metabolism by HK2. PMID: 25738944
顯示更多

收起更多
亞細(xì)胞定位：

Cytoplasm. Nucleus. Note=Mainly found in the cytoplasm in non-metastasizing tumors.
組織特異性：

Preferentially expressed in metastasizing tumors.
數(shù)據(jù)庫鏈接：

HGNC: 30215

OMIM: 612646

KEGG: hsa:346389

STRING: 9606.ENSP00000328410

UniGene: Hs.598388

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human